HRD

About

Biomarker type: Homologous recombination

Status: Deficient

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations Biomarkers Cancer types Therapies
EMA (1) FDA (1) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
EMA (1) FDA (1) HRD High-Grade Serous Fallopian Tube Cancer Bevacizumab, Olaparib
EMA (1) FDA (1) HRD Peritoneal Serous Carcinoma Bevacizumab, Olaparib